Sands Capital has announced it has closed its third life sciences fund, Sands Capital Life Sciences Pulse Fund III, with $555 million.

Through the new fund, the firm indicated it will continue to pursue businesses in private therapeutics, diagnostics, medical…

Vista Equity Partners will acquire Model N (NYSE: MODN) for approximately $1.25 billion, according to a news release.

Model N, founded in 1999 and based in San Mateo, Calif., is a provider of revenue optimization and compliance software…

SK Capital Partners has announced the closing of its latest fund with $2.95 billion in commitments.

The new fund, SK Capital Partners VI, was oversubscribed.

SK Capital Partners, based in New York, is a private equity firm focused on…

New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports.

ILC, founded in 1947 and based in Frederica, Del., designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device…

Arsenal Capital Partners will acquire Fortrea’s enabling services segment and patient access businesses, according to a news release.

Fortea (Nasdaq: FTRE), a global clinical research organization based in Research Triangle Park, N.C., is divesting its Endpoint Clinical and Fortrea…

Linden Capital Partners has announced the acquisition of Alcresta Therapeutics.

Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

Linden…